Neimeth International Pharmaceuticals Plc (NGX:NEIMETH)

NGX:NEIMETH Revenue

Neimeth International Pharmaceuticals had revenue of 1.75B NGN in the quarter ending March 31, 2026, with 45.20% growth. This brings the company's revenue in the last twelve months to 7.91B, up 56.92% year-over-year. In the year 2025, Neimeth International Pharmaceuticals had annual revenue of 7.37B with 64.29% growth.

• Revenue (ttm): 7.91B
• Revenue Growth: +56.92%
• P/S Ratio: 5.56
• Revenue / Employee: 36.64M
• Employees: 216
• Market Cap: 44.01B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	7.37B	2.88B	64.29%
Dec 31, 2024	4.49B	2.28B	102.98%
Dec 31, 2023	2.21B	-709.73M	-24.31%
Dec 31, 2022	2.92B	216.47M	8.01%
Sep 30, 2022	2.70B	-343.81M	-11.28%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 25, 2026

Data Sources Report a data error